See you in London!


GTAD 2024

 

Visit our booth #2 I  May 22- 24, 2024  I  London 

 

The PROGEN team is looking forward to engaging discussions, insightful sessions and networking opportunities with longterm customers, partners and old friends, as well as meeting new faces in the gene therapy field.

 

So make sure to drop by our booth #2 and say hello or come and catch up with us at the networking sessions.

 

And don´t forget to visit our posters and attend our presentations.

 

Looking forward to meeting you there!

 

 

Meet the Team


 

Caroline Odenwald

Head of Marketing

 Get in contact with Caroline

 

 

 

Manja von Hahn

Junior Account Manager

 Get in contact with Manja

 

Oral Presentation 


 

Join us on Thursday at 1.30 pm, as this talk uncovers the current challenges of AAV-based gene therapy and how they can be adressed with our ELISA.

Titel: AAV Capsid Titer Determination - meeting current challenges

Presenter: Caroline Odenwald I Head of Marketing 

11.30 pm I Thursday May 23, 2024

 

 

  • Current challenges of AAV titer determination
  • High throughput & automation
  • Orthogonal methods by comparison 

Poster Presentations


AAV CapsideTiter Determination of AAV Standard Material by Orthogonal Methods

Download our poster to explore characterization data of human chimeric AAV antibodies. Here we take a closer look at cross-reactivity, sensitivity and neutralizing activities in comparison with mouse monoclonal antibodies.

Caroline Odenwald I Head of Marketing, PROGEN
Thursday I May 23 I 02.30pm

Download Poster

Determination of Full: Empty ratio of AAV Standard Material by Orthoginal Methods

Download our poster to explore characterization data of human chimeric AAV antibodies. Here we take a closer look at cross-reactivity, sensitivity and neutralizing activities in comparison with mouse monoclonal antibodies.

 

Caroline Odenwald I Head of Marketing, PROGEN
Thursday I May 23 I 02.30pm

Download Poster

AAV Capsid ELISA Automation for High-throughput AAV Titer Determination

Download our poster to explore characterization data of human chimeric AAV antibodies. Here we take a closer look at cross-reactivity, sensitivity and neutralizing activities in comparison with mouse monoclonal antibodies.

 

Manja von Hahn I Junior Account Manager, PROGEN
Thursday I May 23 I 02.30pm

Download Poster

Interested in learning more about AAVs? 


 

Get the latest on AAV with our library of informative articles, new product announcements, customer stories and get to know the PROGEN team.

 

Blog Center

 

Know what you need?

Login and order directly
from your account

Order now

Need more information?

Visit our support hub for FAQs,
references and downloads.

Visit support hub